Integra LifeSciences Holdings (IART)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -6,943 -6,544 23,648 40,234 67,741 100,853 131,271 171,875 180,550 172,988 166,302 156,582 169,075 216,435 205,543 170,106 133,892 56,467 -3,480 26,625
Revenue (ttm) US$ in thousands 1,596,615 1,533,335 1,521,985 1,473,066 1,486,381 1,488,778 1,493,656 1,509,844 1,505,291 1,519,581 1,519,648 1,510,233 1,535,982 1,529,270 1,504,267 1,371,086 1,317,264 1,323,744 1,339,441 1,466,719
Net profit margin -0.43% -0.43% 1.55% 2.73% 4.56% 6.77% 8.79% 11.38% 11.99% 11.38% 10.94% 10.37% 11.01% 14.15% 13.66% 12.41% 10.16% 4.27% -0.26% 1.82%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-6,943K ÷ $1,596,615K
= -0.43%

The net profit margin of Integra LifeSciences Holdings has shown fluctuating trends over the analyzed periods. From March 31, 2020, to June 30, 2021, there was a significant improvement in the net profit margin, reaching a peak of 14.15% on September 30, 2021. However, the margin declined in the subsequent quarters, dropping to 4.56% by December 31, 2023.

It is important to note that the net profit margin turned negative in the last two quarters of 2024, indicating that the company's expenses exceeded its revenues during those periods. This negative trend could be a cause for concern, as it suggests challenges in profitability management that may need to be addressed by Integra LifeSciences Holdings.